DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Pfützner A, Lorra B, Abdollahnia MR, Kann PH, Mathieu D, Pehnert C, Oligschleger C, Kaiser M, Forst T.
The switch from sulfonylurea to preprandial short- acting insulin analog substitution has an immediate and comprehensive beta-cell protective effect in patients with type 2 diabetes mellitus.
Diabetes Technol Ther 2006; 8: 375-384
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.